|Publication number||US7141152 B2|
|Application number||US 10/389,250|
|Publication date||Nov 28, 2006|
|Filing date||Mar 14, 2003|
|Priority date||Mar 16, 2000|
|Also published as||US20030226754|
|Publication number||10389250, 389250, US 7141152 B2, US 7141152B2, US-B2-7141152, US7141152 B2, US7141152B2|
|Inventors||David A. Le Febre|
|Original Assignee||Le Febre David A|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (33), Non-Patent Citations (18), Referenced by (20), Classifications (13), Legal Events (2)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application claims priority to U.S. provisional patent application Ser. No. 60/364,709 filed Mar. 14, 2002, and is a continuation in part of the nonprovisional U.S. patent application Ser. No. 09/526,920 filed Mar. 16, 2000, now U.S. Pat. No. 6,749,735, the disclosures of which are hereby incorporated herein by reference.
1. The Field of the Invention
The present invention relates generally to separation of analyte species in an analyte sample. More particularly, the present invention relates to a fraction collector configured for separating and collecting an analyte species from an analyte sample containing a plurality of analyte species and enabling such a separation on a continuous basis if desired.
2. Description of Related Art
The ability to separate a particular analyte species from an analyte sample is a common requirement in biological research. Likewise being able to separate a particular substance from a mixture of substances is often a requirement in pharmaceutical manufacturing. For example, the ability to separate an individual protein from a mixture of proteins is desirable in research and in the manufacturing of certain medicaments. For convenience, the terms “analyte” and “analyte species” will be used herein to refer to a sample containing a plurality of different substances, and the individual substances, respectively. Typically, these will be substances comprising molecules having a net charge (e.g. protein molecules, amino acid molecules, and DNA molecules).
HPLC, gel electrophoresis and CE typically offer a “single pass” means of separating a mixture of substances into separate substances or isolating a particular substance or group of substances. However, it is generally not efficient to do multiple separations to increase the quantity of obtained sample of one substance separated out from the sample mixture. A more efficient method is to provide a continuous separation. One method of doing this is called “Simulated Moving Bed” or SMB, which consists of switching segments of a conventional separation column in such a manner that the apparatus will allow a continuous fluid mixture including analyte to be flowing into one end of the column, and a continuous flow of a separated analyte species from the column output, while a second output discharges the remainder of the fluid mixture. Most SMB apparatus configurations comprise many packed columns, each similar to an HPLC column, for example, which are switched sequentially at time intervals to simulate a counter-flowing moving bed.
For continuous separation of analyte species, e.g. individual proteins, in complex analyte mixtures, conventional SMB processes do not work well because the HPLC columns have limited resolution, and conventional known substitutes for this method are likewise limited. Even for relatively simple analyte sample mixtures, the stationary phases used in a conventional SMB require a relatively large amount of development time to optimize the separation; and, in some instances, the stationary phase in the columns becomes very expensive.
It has been recognized that it would be advantageous to develop a system for the separation of analyte species which allows efficient separation of analyte species from analyte samples; including, but not limited to, very complex analyte samples such as blood, urine, or spinal fluid; and which can perform such separations on a continuous basis if desired. The invention accordingly provides an analyte species separation system configured to separate an analyte species of interest from other analyte species in an analyte sample. The system includes: a) a separation flow field in a fluid medium disposed between a first confining surface and a second confining surface, said flow field having a first flow component flowing in a first direction and a second flow component flowing in a second direction, said second direction being transverse to said first direction; b) an electric field configured to cause analyte species to move in the separation flow field in a direction opposite to the first direction; c) an analyte separation target channel, or collector, adjacent and in fluid communication with the flow field; and d) an analyte injection channel in fluid communication with the flow field, said analyte injection channel being disposed so that an analyte sample injected into the flow field from the analyte injection channel traverses at least a portion of the flow field toward the target channel in a direction having a vector component parallel with the second direction, and said second flow component of the flow field flowing from the analyte injection channel toward at least the target channel (collector); the system enabling analyte species to be moved in relationship to each other in directions parallel to the first direction by interaction of the first flow component and the electric field, the amount of movement being related to the mobility of the respective analyte species in the fluid medium under influence of the electric field, said analyte species being moved so as to be separated spatially in directions parallel to the first direction and also move in the second direction through the flow field so that analyte species having mobilities outside a selected mobility range do not enter the target channel and an analyte species of interest having a mobility within a selected range is directed to, and enters, the target channel or collector.
Additional features and advantages of the invention will be set forth in the detailed description which follows, taken in conjunction with the accompanying drawing, which together illustrate by way of example, the features of the invention.
Like reference numbers refer to similar elements in the embodiment(s) shown throughout the figures.
For the purposes of promoting an understanding of the principles of the invention, reference will now be made to the exemplary embodiments illustrated in the drawings, and specific language will be used to describe the same. It will nevertheless be understood that no limitation of the scope of the invention is thereby intended. The subject matter discussed herein builds upon concepts disclosed in U.S. patent application Ser. No. 09/526,920 filed on Mar. 16, 2000, now U.S. Pat. No. 6,749,735 from which this application examples priority for the subject matter in common. As mentioned above, the disclosure of that reference is incorporated herein by reference.
With reference to
An electric potential is applied across the flow field 12, actually through or at least adjacent the first inflow and outflow channels, 20, 22, by means of a cathode and anode (not shown) associated therewith, and the fluid and/or a stationary phase therein is conductive to provide an electric field in the fluid as is known in the art. The electric field is configured to cause analyte species, more particularly exemplified by particles or molecules having a net charge, such as proteins, DNA molecules and DNA fragments, amino acids, colloidal particles, etc, having a charge associated therewith, to move in the flow field in a direction having a vector component opposite of a flow direction of the first flow component 18. The electric field intensity can be locally varied within the flow field to more particularly manipulate the forces on analyte species to achieve improved separation, isolation of a particular species or group of species having a mobilities within a certain selected range in the flow field due to the electric field, bring about continuous separations of analyte species of interest, and other operational and design goals.
For example, one or both of the confining surfaces 14, 16 can further comprise a contour resistor 34 which is configured to be in electrical contact with the fluid in the flow field 12. A number of discrete contour resistors can alternatively be provided. The contour resistor can provide local variation in electrical resistance in the flow field, locally varying the electric field intensity by providing a shunting current path for electrical current in the fluid. The resistance of this shunting path is made different in different locations, for example by variation of such parameters as composition, density, and/or geometry, of resistive material locally. This can be done for example by varying the thickness of the material, or varying a patterned deposition of resistive/conductive materials, or varying the composition of resistive material, to name some examples. This allows the intensity of the electrical field at each location in the flow field to be specified.
By means of these arrangements separation of analyte species can be accomplished. For example an analyte species cation 36 introduced into the flow field 12 from the injection channel 26 is acted on by at least two forces, a hydrodynamic force resulting from the first flow component 18 and the electric field acting in the opposite direction. Thus, if it has a high mobility it will move toward the first inlet channel 20, and a low mobility it will move toward the first outlet 22, in the flow field. At the same time it is acted on by the electric field and the first flow component, it is also acted on by the second flow component 24. This moves it towards the target channel 28. The system 10 is adjusted so that a selected analyte species having a particular mobility will migrate into the target channel due to the interaction of the first and second flow components and the electric field. Analyte species having mobilities above and below that of the selected analyte species, or the range of mobilities of a number of species selected, are received in the rejection channels or migrate into the first inlet or outlet channels. The salient point here being that analyte species are made to move relative to one another based on their relative mobilities in the fluid due to the interaction of the first flow component and the electric field, allowing separations.
The target channel 28 and one or more rejection channel(s) 30, 32 can lead to further collection arrangements and/or further processing steps (not shown) as will be further described below. Examples of pathways the exemplary analyte species cation 36 can follow depending on its mobility in the flow field under influence of the electric field are illustrated in
With reference now to
The electric field intensity in this embodiment this is configured with a central “flat” section in a central portion of the flow field where the analyte species having a mobility in the range to be received in the target channel are focused. This flat portion is as long or longer than the target channel is wide. This is done so that essentially all the analyte species received in the target channel are of the “targeted” mobility. Examples of variations of this profile are shown in
In the exemplary embodiment the hydrodynamic counter force is an electroosmotic flow EOF generated in one or both of the inlet and outlet channels 20, 22; and here V1 and V3 are equal in flow. Unlike electromobility focusing disclosed in the parent case, a second orthogonal flow component 24 is generated, and this contains the sample mixture. This flow has the condition that V2 equals V4, V5 and V6. Here again, in one embodiment all flows in the injection channel and target and rejection channels are electroosmotically generated. Thus, two orthogonal flow components coexist within a chamber defined by the first and second confining surfaces 14, 16 comprising top and bottom surfaces of a channel 52 and sides of the channel, and coextending with a variable resistance contour resistor 34 disposed on at least one of the confining surfaces. In an exemplary embodiment, the chamber is about 4000 μm by 4000 μm and about 50 μm high. This defines the volume of the flow field. Both of the confining surfaces are dimensioned at about 4000 μm by 4000 μm and embody contour resistors. These are configured to locally vary in their resistance, but vary only in the x-axis direction. Control surfaces (not shown) to establish the EOF for precisely controlled flows to establish the hydrodynamic counter force for separation and the flow component for moving the sample through the flow field are located in each of the six “legs” comprising the first and second inlets and outlets 20, 22, 26, 28, 30, 32 but not in the square chamber 52 confining the flow field 12 itself. The electric field intensity gradient is generated by an isolated power supply (not shown), which also generates EOF flows V1 and V3 using control surfaces in each of the legs. Another power supply (not shown) referenced to ground generates V2, V4, V5 and V6.
A sample mixture comprising individual proteins and electrolyte is moved into the flow field with a velocity determined by the control surfaces of leg 2 comprising the injection channel 26. Once the individual proteins are within the square chamber 52 flow field 12, the proteins are affected by three independent forces: a hydrodynamic force comprising the second flow component comprising V2; the electric field intensity gradient; and the first flow component comprising the hydrodynamic counter force comprising V1. The gradient and counter force will cause a protein 56 traveling within the flow field to reach an x-axis equilibrium position as it travels along the y-axis. Once the protein reaches the upper part of the flow field square in
As shown in
The contour of the electric field intensity gradient to a great extent determines the degree of selectivity the system 10 has to the desired protein, or in other words, how efficiently the selected protein will be isolated, and how effectively the other proteins are rejected. The cooperation of the electric field and the counter force produces the force regime which influences, among other things the speed of the separation process in the x-direction. The electric field intensity gradient continuum with counter force accordingly provides the means to separate a selected protein (or a group of proteins having similar mobilities) from a sample mixture 54 including other proteins. The profile of the electric field intensity gradient shown in
Continuing with description of an exemplary embodiment, with reference to
Since both power supplies for Legs 1 and 3 are isolated, the electrolyte flowing in either leg is the same, and the first flow component 18 comprises a volume of flowing fluid confined only to these two legs. The amounts of leakage current across the supply transformers determine the amount of electrolyte fluid cross flow into Legs 2, 4, 5 and 6. If the supplies are isolated at the primary transformer, the leakage current is minimal. For example, using a low leakage current transformer (115 volts to 24 volts available commercially from Advanced Components Industries, Inc. Torrance, Calif., Part Number 0142400-1-0000), followed by a DC to DC converter of 24 volts to 2500 volts) the current leakage is less than 1×10−9 amps with 5000 volts DC applied to the primary or secondary. For a typical current of 0.5 to 5 milliamps flowing in Legs 1 and 3, the DC leakage current is 1,000,000 times less than the Leg current, resulting in virtually no electrolyte fluid volume comprising the flow through legs 1 and 3 flowing into the other legs, or fluid volume from the other legs being drawn into the flow from Leg 1 to leg 3. Legs 2, 4, 5 and 6 are driven by the lower supply electrode 66, the upper supply electrode 68 and the sample recovery reservoir electrode 70. The voltages of the upper supply electrode and the recovery reservoir electrode can be biased to the same value. The voltage drop required across these later-mentioned leg segments is dictated by a minimal electric field intensity sufficient to drive the system, e.g. 100 to 300 volts/cm. If all of the legs are 4 cm long, then the lower supply electrode is −800 volts and the upper supply electrode is +800 volts for an electric field intensity of 200 V/cm. The selected voltages place the center of the chamber 50 in the y-direction at near zero volts and a total voltage swing across the y-axis of +/−80 volts and the x-axis of +800 volts to −400 volts.
A reasonable required design residence time in the flow field 12 of a protein cation 56 is the time required for it to propagate from one side (y=0 μm) of the chamber 50, to the opposite side (y=4000 μm). A minimum design residence time is established by the slowest protein's orthogonal (x-axis) propagation from the center of the flow field in the channel chamber in the x-direction to the x-axis location of low mobility branch (leg 4) rejection channel 32. To improve throughput the input (leg 2) comprising the injection channel 26 is intentionally offset “downstream” on the x-axis to reduce this lateral transition time. (This possibility is illustrated in
The selected protein's mobility can be altered by changing the pH of the electrolyte away from the isoelectric point of the selected protein to increase the mobility of the protein and hence reduce its residence time in the flow field 12 in the chamber 50. The propagation time of the selected protein from the injection channel, leg 2, to the target channel, leg 5, is determined by its mobility and the electric field intensity (in this case 300 V/cm). Therefore, if, for example, the width of the outlet into the flow field of leg 2 and inlet to leg 4 is 200 μm, then the worst-case lateral (x-axis) travel of the selected protein is 200 μm or for a protein with a mobility of 1×10 −5 cm/V-sec, and the time to travel the required 200 μm is 6.6 seconds. This then establishes that a sample source fluid velocity, V2, in the must be chosen so that the analyte species protein of interest has a minimum time to transit the specified diagonal distance across the flow field in the y-direction and across the required x-direction offset, if any, of at least 6.6 seconds. In the example, the diagonal distance between leg 2 and leg 5 is a diagonal line of 4.005 mm resulting in a velocity of 0.607 mm/see (0.0607 cm/see). This corresponds to a volume of (200 μm×50 μm×4000 μm) or 40×10−12 cubic meters or 40 nL per 6.6 sec or 6.06 nL/sec or 21.8 μL/hr or 523.2 L/24 hrs. Optimizing the pH to increase the selected protein's mobility could potentially increase the separated volume by a factor of 10 in some cases. Also, decreasing the width of Leg 3 and Leg 5 decreases the x-axis travel distance with a corresponding increase in throughput.
The degree or efficiency of rejection is governed by the difference in the electric field intensity gradient between leg 4 and leg 5 and between leg 6 and leg 5. For an inflected gradient where the center of inflection corresponds with a centerline of leg 5, the differential gradient is about the same. However, in practice there is not true symmetry since the lateral forces (V1 and V3) are biased by E(x).
Continuing with the example, for separation of a protein with an electrophoretic mobility of 1×10−5 cm2/V-sec the counter force (V1 “source” and V3 “sink” flow) is 3×10−3 cm/sec. At 1.9 mm (x-axis) the electric field intensity is −299.6329 V/cm resulting in a lower limit of mobility of 1.00122×10−5 cm2/V-sec and at 2.1 mm the electric field intensity is 300.5267 V/cm resulting in an upper limit of mobility of 0.99825×10−5 cm2/V-sec. This results in a differential mobility window for leg 5 with a width of 200 μm of 2.97×10−8 cm2/V-sec.
In separating protein samples 54 with very low concentrations, the width of the target channel 28 comprising leg 5 may be substantially reduced resulting in a corresponding increase in selectivity. In example set forth above, decreasing the width of the opening into the target channel comprising leg 5 from 200 μm to 20 μm decreases the mobility width of the window to 2.97×10−9 cm/V-sec.
With reference to
As will be appreciated, each stage is provided with isolated cathodes and anodes connected to isolated power supplies, for the same reasons as discussed above, including isolating flow components in the flow fields and minimizing cross flows. The second flow component in each and all the stages 69, 70, 72 in the exemplary embodiment illustrated is controlled by the EOF induced in the y direction through the system by the primary anode 74 and cathode 76. A sample recovery reservoir 78 is associated with the primary anode. In another embodiment, isolating each anode and cathode can be done, and this allows greater design flexibility, and flexibility in operation, as it is possible to selectively provide different isolated voltages across different pairs of anodes and cathodes throughout the system.
As mentioned above, a sufficiently precise small volume pump (not shown) can also be used in each case to provide the hydrodynamic flow in each of the stages and/or to provide the second flow component in each case, some cases, or in all cases, to move the sample through the successive stages.
In other embodiments, it is also possible to change the profile of the electric field intensity gradient for each successive stage to further increase the separation power of the device and/or change the width of the sample target channel and/or the size and shape of the flow field in each of the following stages to increase throughput or increase resolution. Also, depending on whether it is desired at a particular stage to pass all of an analyte species in the sample, even if it means also passing at least some other analyte species having similar mobilities, or it is desired to pass on only a desired species or group of species, even if some of the selected analyte species is “lost” to rejection channels, the profile of the electric field intensity gradient with respect to the x-axis can be altered to facilitate these goals.
For example, as shown in
Also, unlike electromobility focusing where generally speaking a field intensity continuum, that is to say a smooth function, is desirable, in a staged system discontinuities can be helpful to enhance spatial separations. For example, profiles 83, 85, 86, and 88 are similar to profiles 80 and 84 just discussed but a sharp or sudden change in slope 87 or a discontinuity 89 provides a more definite and locatable “bright line” separation feature enabling the edges of the mobility range in question to be more positively located with respect to the target channel, so as to be well inside, well outside, or substantially correspond with the width extent of the target channel. The discontinuity can comprise a sudden change in conditions in the flow field, for example a sudden change in the width of the channel 52 carrying the first flow component within the chamber 50, or a conductive strip interrupting the contour resistor where an isolated potential is applied to suddenly shift the profile 86, 88, to name a few examples. As will be appreciated however, in practice a precise and sharp change in the field intensity providing such a “bright line” is difficult to achieve. But an approximation provided by this embodiment can in some cases provide substantially the functionality just described.
It should also be noted that in another embodiment the rejection channels could also be connected to further stages for additional processing, allowing for a branch approach to separation of multiple mobility species. Also, it will be apparent that collection reservoirs (not shown) can be provided at a termination of the rejection channels, and sample collected there can be transferred to another similar system for further separations. Such a branching approach can potentially enable isolation of a large number of separate analyte species, even in a relatively large throughput and/or continuous process application.
Another approach is to lay down the resistor by use of a multi-ink (similar to multi-color) ink jet print head to deposit multi-compositional (different ink resistivities) drops to produce the x-axis resistance gradient. Thus to get a specific dot resistance, multiple drops are deposited on top of one another and diffuse together to form a composite. Therefore, each line in the y-axis has the same resistance but adjacent lines have slightly different resistances. There is also diffusion between lines to smooth the resistance profile in the x-axis. As an example, a computer-controlled plotter would perform the ink deposition by incrementing an x-y platform and the ink can be deposited from 8 different ink jets (100 ohms/square, 1000 ohms/square, 10,000 ohms/square, 100 kilohms/square, 1 megohms/square, 10 megohms/square, 100 megohms/square, and 1000 megohms/square). Each drop can consist of two or more inks. Each ink jet would generate a 10 μm diameter drop, which should be positioned within a spatial location of +/−1 μm. A 4000 μm×4000 μm planar contour resistor can comprise 160,000 dots (10 μm diameter) and at a rate of 100 dots per second (per row) and 1 second to switch between rows such a contour resistor would require less than an hour to deposit on a substrate forming the confining surface 14 or 16. Carbon-doped thermal set epoxy inks are commercially available. For example, such inks can be obtained from Metech, Inc. of Elverson, Pa. which product nos. 8511 through 8561, for example, correspond with resistivities of 10 ohms/square to 10 megaohms/square.
In another embodiment the contour resistor can be formed using photo-resist and/or thin film techniques to provide improved resolution. Ion implantation such as used in semiconductor manufacturing processes can also be used to provide increased resolution. However, the cost of manufacture can also rise with these techniques, and they typically require a large production quantity to be economical. Commercial-scale production of a disposable system for a widespread testing application can employ one or more of these latter techniques for example.
With reference now to
Each substrate 90, 92 has thick-film distributed resistors 102, 104, 106, 108, 110 and 112 corresponding to the channels 20, 22, 26, 28, 30 and 32, respectively, discussed above, screen printed thereon in mirror-image fashion. These comprise EOF control surfaces disposed above and below and essentially co-extensive with, the channels, to provide flow control. In another embodiment where precisely controlled pumps are used for flow control these control surfaces can be eliminated, simplifying the configuration. Returning to the illustrated embodiment, conductors, referenced by even numbers 114–132, are also screen printed on the inner surfaces of the substrates in essentially mirror image fashion. Dielectric bridges between conductors and distributed resistors and other conductors where they cross but need to be electrically isolated are also laid down. The printing processes are followed by deposition of high K dielectric layers 96, 98 over the substrates. The high K dielectric layers form the upper and lower portions of the channels and the spacer defines the sides and height extent of the channels. The contour resistors 34 defining the confining surfaces 14, 16 are deposited on the dielectric layers 96, 98 as discussed above. In an alternate embodiment the dielectric layers can be separate layers which are attached to the printed substrates. In assembly of the device 100 the substrates with dielectric layers thereon are sandwiched together with the spacer located intermediate the two substrates. As will be appreciated, precision in registration of the printing processes and layer assembly is important.
The substrates 90, 92 are made from material comprising 97% alumina. In the illustrated embodiment they are 0.125 to 0.25 inches thick. In one embodiment they are lapped smooth and the inner surfaces prepared so as to be suitable for thick or thin film deposition by screen printing. As discussed, subsequently screen-printed on the substrate are the distributed resistors 102–116, and dielectric bridges (not specifically shown, but present between crossing elements as required) followed by conductors 114–132, which form electrical contact with the distributed resistors and provide a means to electrically drive the conductors from the exterior of the device. On top of these screened resistors and conductors in each case is deposited the dielectric layer 96, 98 which actually can comprise three or more layer depositions of thermal-set filled epoxy (each layer is 14 to 25 microns thick). The epoxy is loaded with 30 to 50% 0.5 to 5.0 micron BaTiO2 powder. The high K filled epoxy further comprises a resin and an aliphatic amine curing agent. At room temperature it has a volume resistivity of 1×1015 ohm-cm and a surface resistivity of 5×1016 ohm-cm. The BaTiO2 powder is thoroughly mixed into the epoxy and out-gassed before the screening operation. Each layer is cured at 225 degrees C. prior to the screening of the next layer. After curing the filled epoxy, the contour resistors 34 are deposited on top of the dielectric.
It should be noted that each successive layer is fabricated using a lower temperature than the previous layer. The alumina substrate has the highest continuous use temperature of over 1200 degrees C., followed by the inorganic thick film distributed resistors and conductive inks, which are processed at 850 to 875 degrees C., followed by the thermal-set filled epoxy, which is processed at 250 degrees C. and finally the contour resistors, which are processed at 220 degrees C.
As discussed, the upper and lower substrates are mirror images of each other; however, the upper substrate 90 has thru holes formed in the alumina substrate, and the upper dielectric layer likewise has openings formed therein for fluid connections to the various channels discussed. KOVAR tubing segments 140, 142, 144, 146, 148 and 150 for the various connections are disposed in the holes in the substrate, which arrangement allows for the attachment of plastic tubing to carry electrolyte and the sample to and from the channels, reservoirs, etc.
In assembly the spacer 94 is precisely placed over and onto the structure of the lower substrate 92 and dielectric layer 98 over a layer of adhesive. The upper substrate assembly 90, 96, etc. with an adhesive layer thereon is precisely located over and placed onto the spacer, and they are brought together. clamps are subsequently secured around the assembly and the resulting sandwich is compressed. In one alternative embodiment this procedure is done using instead a 5-mil heat tolerant sheet spacer with adhesive deposited on each side, like a double-sided tape, which is die cut to provide the fluid channel configuration. In another embodiment a known thickness of epoxy is screened onto a substrate assembly over the other layers deposited, and spheres of uniform diameter matching the desired thickness of the spacer are either contained in the uncured epoxy or are added to at least the peripheral locations of the uncured epoxy. After the other substrate has been placed on top in proper registration, pressure and heat are applied to cure the epoxy. In another alternative, the spacer can be provided by a die-cut thermal plastic layer, which is heated between the substrates while pressure is applied. The plastic is heated sufficiently above the use temperature so as to soften so as to adhere to the upper and lower substrates on either side, then cooled.
With reference to
The offset amplifiers 152, 154, 164, 166 at the upper and lower ends of the channel 52 comprising a composite of legs 1 and 3 together with the chamber 50, interface to the upper and lower electrodes (62, 62 in
With reference to
Moreover, at least as to V1 and V3 the pumps can be ganged together to form a push/pull (pressure/vacuum) flow regime. For example, such a precision push-pull pump, comprising ganged syringe pumps and denominated Product No. SP120p, is available from World Precision Instruments of Sarasota Fla. In one embodiment a second precision pump is configured to provide V2. A counterpart flow divided into and comprising V4, V5, and V6 flows through several centimeters of path length in each one of the downstream rejection channel 32, the target channel 30, and upstream rejection channel 28, to exit at atmospheric pressure. In one embodiment the flow component 24 in the y-direction is kept small enough that differences in pressure drop along the target channel and rejection channels due to relative differences in size or outlet arrangements is negligible and not a factor in the separation. In another embodiment the target channel and rejection channels are configured in relation to the magnitude of the flow so that there is a difference in pressure drop influencing the separation, for example directing relatively more or less flow into a particular channel 28, 30 or 32 compared with the others.
This latter-described embodiment is particularly cost effective in a disposable as complexity is moved off the substrates 90, 92 and onto the non-disposable portions of the instrument. It will be appreciated that the syringes and fluid connections can be disposables also, but are of relatively low cost.
From the foregoing it will be apparent that the system 10 enables efficient separation of analyte species, and doing so on a continuous bases. This enables separations in many research and commercial applications which heretofore were not practicable.
It is to be understood that the above-described arrangements are only illustrative of the application of the principles of the present invention. Numerous modifications and alternative arrangements may be devised by those skilled in the art without departing from the spirit and scope of the present invention and the appended examples are intended to cover such modifications and arrangements. Thus, while the present invention has been shown in the drawings and fully described above with particularity and detail in connection with what is presently deemed to be the most practical and preferred embodiment(s) of the invention, it will be apparent to those of ordinary skill in the art that numerous modifications, including, but not limited to, variations in size, materials, shape, form, function and manner of operation, assembly and use may be made, without departing from the principles and concepts of the invention.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US4323439 *||Dec 31, 1979||Apr 6, 1982||The Regents Of The University Of California||Method and apparatus for dynamic equilibrium electrophoresis|
|US4698142 *||Jul 31, 1985||Oct 6, 1987||Hitachi, Ltd.||Free-flow electrophoretic separation method and apparatus therefor|
|US5092972||Jul 12, 1990||Mar 3, 1992||Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College||Field-effect electroosmosis|
|US5151164||Feb 9, 1990||Sep 29, 1992||The University Of Maryland||Enhanced capillary zone electrophoresis and apparatus for performance thereof|
|US5180475||Sep 4, 1991||Jan 19, 1993||Hewlett-Packard Company||System and method for controlling electroosmotic flow|
|US5180480 *||Jan 13, 1992||Jan 19, 1993||Ciba-Geigy Corporation||Apparatus for the preparation of samples, especially for analytical purposes|
|US5262031||Feb 7, 1992||Nov 16, 1993||Hewlett-Packard Company||Electroosmotic flow control apparatus for capillary electrophoresis|
|US5282942||Jan 22, 1993||Feb 1, 1994||Beckman Instruments, Inc.||Methods and apparatus for separating and mobilizing solutes in a solute mixture|
|US5320730||Jan 22, 1993||Jun 14, 1994||The Penn State Research Foundation||Capillary electrophoresis apparatus with improved electroosmotic flow control|
|US5441613||Dec 3, 1993||Aug 15, 1995||Dionex Corporation||Methods and apparatus for real-time monitoring, measurement and control of electroosmotic flow|
|US5482608 *||Jan 19, 1993||Jan 9, 1996||Hewlett Packard Company||Capillary electrophoresis flow control system|
|US5728282||Apr 12, 1996||Mar 17, 1998||Molecular Dynamics||Denaturing separation matrix having hydroxyethyl cellulose for nucleic acid electrophoresis|
|US5750015||Mar 13, 1996||May 12, 1998||Soane Biosciences||Method and device for moving molecules by the application of a plurality of electrical fields|
|US5800690||Jul 3, 1996||Sep 1, 1998||Caliper Technologies Corporation||Variable control of electroosmotic and/or electrophoretic forces within a fluid-containing structure via electrical forces|
|US5810985||Feb 9, 1995||Sep 22, 1998||Purdue Research Foundation||Electrophoretically mediated chemical analysis|
|US5882465||Jun 18, 1997||Mar 16, 1999||Caliper Technologies Corp.||Method of manufacturing microfluidic devices|
|US5900934||Oct 6, 1997||May 4, 1999||Waters Investments Limited||Capillary chromatography detector apparatus|
|US5948227||Dec 17, 1997||Sep 7, 1999||Caliper Technologies Corp.||Methods and systems for performing electrophoretic molecular separations|
|US5955028||Aug 14, 1997||Sep 21, 1999||Caliper Technologies Corp.||Analytical system and method|
|US5957579||Sep 30, 1998||Sep 28, 1999||Caliper Technologies Corp.||Microfluidic systems incorporating varied channel dimensions|
|US5958202||Jan 22, 1997||Sep 28, 1999||Perseptive Biosystems, Inc.||Capillary electrophoresis enzyme immunoassay|
|US5958203||Jun 26, 1997||Sep 28, 1999||Caliper Technologies Corportion||Electropipettor and compensation means for electrophoretic bias|
|US5958694||Oct 16, 1997||Sep 28, 1999||Caliper Technologies Corp.||Apparatus and methods for sequencing nucleic acids in microfluidic systems|
|US5959291||Jun 25, 1998||Sep 28, 1999||Caliper Technologies Corporation||Method and apparatus for measuring low power signals|
|US5964995||Apr 4, 1997||Oct 12, 1999||Caliper Technologies Corp.||Methods and systems for enhanced fluid transport|
|US5965001||Jul 3, 1997||Oct 12, 1999||Caliper Technologies Corporation||Variable control of electroosmotic and/or electrophoretic forces within a fluid-containing structure via electrical forces|
|US5965410||Nov 25, 1997||Oct 12, 1999||Caliper Technologies Corp.||Electrical current for controlling fluid parameters in microchannels|
|US5972187||Mar 20, 1998||Oct 26, 1999||Caliper Technologies Corporation||Electropipettor and compensation means for electrophoretic bias|
|US5976336||Apr 25, 1997||Nov 2, 1999||Caliper Technologies Corp.||Microfluidic devices incorporating improved channel geometries|
|US5989402||Aug 29, 1997||Nov 23, 1999||Caliper Technologies Corp.||Controller/detector interfaces for microfluidic systems|
|US6001229||Aug 1, 1994||Dec 14, 1999||Lockheed Martin Energy Systems, Inc.||Apparatus and method for performing microfluidic manipulations for chemical analysis|
|US6010608||Sep 16, 1998||Jan 4, 2000||Lockheed Martin Energy Research Corporation||Apparatus and method for performing microfluidic manipulations for chemical analysis and synthesis|
|US6277258||May 6, 1999||Aug 21, 2001||Washington State University Research Foundation||Device and method for focusing solutes in an electric field gradient|
|1||Andras Guttman, Bart Wanders, & Nelson Cooke, Enhanced Separation of DNA Restriction Fragments by Capillary Gel Electrophoresis Using Field Strength Gradients, Anal. Chem. 1992, 64, 2348-2351.|
|2||Bruce R. Locke & Ruben G. Carbonell, A Theoretical and Experimental Study of Counteracting Chromatographic Electrophoresis, Separation & Purification Methods, 18(1), 1-64 (1989).|
|3||Charles R. Cantor, Cassandra L. Smith & Matthew K. Mathew, Pulsed-field Gel Electrophoresis of Very Large DNA Molecules, Ann. Rev. Biophys. Biophys. Chem 1998 17:287-304.|
|4||Cornelius F. Ivory & William A. Goble, Continuous Counteracting Chromatographic Electrophoresis, Biotechnol. Prog. 1990, 6, 21-32.|
|5||Dennison, W.A. Lindner, & N.C. Phillips, Nonuniform Field Gel Electrophoresis, Analytical BioChemistry 120, 12-18 (1982).|
|6||J.M. Mesaros, G. Luo, J. Roeraade, & A.G. Ewing, Continuous Electrophoretic Separations in Narrow Channels Coupled to Small-Bore Capillaries, Anal. Chem. 1993, 65, 3313-3319.|
|7||J.M. Mesaros, P.F. Gavin, & A.G. Ewing, Flow Injection Analysis Using Continuous Channel Electrophoresis, Flow Injection Analysis Using Continuous Channel Electrophoresis, Anal. Chem. 1996, 68, 3441-3449.|
|8||M.D. Biggin, T.J. Gibson & G.F. Hong, Buffer gradient gels and <SUP>35</SUP>S label as an aid to rapid DNA sequence determination, Proc. Natl, Acad. Sci., vol. 80, pp. 3963-3965, Jul. 1983C.|
|9||*||Manz et al, J. Micromech. Microeng. 4 (1994), pp. 257-265.|
|10||Patrick H. O'Farrell, J. Biol. Science vol. 227 Mar. 198 ? Separation Techniques Based on the Opposition of Two Counteracting Forces to Produce a Dynamic Equilibrium.|
|11||Peter F. Gavin & Andrew G. Ewing, Continuous Separations with Microfabricated Electrophoresis-Electrochemical Array Detection, J.Am. Chem. Soc 1996, 117, 8932-8936.|
|12||Robert D. Greenlee & Cornelius F. Ivory, Protein Focusing in a Conductivity Gradient, Biotechnol. Prog. 1998, 14, 300-309.|
|13||Stellan Hjerten, Jia-Li Liao, & Ron Zhang, New approaches to concentration on a microliter scale of dilute samples, particularly biopolymers with special reference to analysis of peptides and proteins by capillary electrophoresis, Journal of Chromatography A.676 (1994) 409-420.|
|14||Timothy C. Scott, Use of Electric Fields in Solvent Extraction: A Review and Prospectus, Separation & Purification Methods, 18(1), 65-109 (1989).|
|15||Tshenge Demana, Maureen Lanan, & Michael D. Morris, Improved Separation of Nucleic Acids with Analyte Velocity Modulation Capillary Electrophoresis, Anal. Chem. 1991, 63, 2795-2797.|
|16||W. Ansorge & S. Labeit, Field gradients improve resolution on DNA sequencing gels, Journal of Biochemical & Biophysical Methods, 10 (1984) 237-243.|
|17||Wendy S. Koegler, Cornelius F. Ivory, Focusing proteins in an electric field gradient, Journal of Chromatography A, 229 (1996) 229-236.|
|18||Zheng Huang & Cornelius F. Ivory, Digitally Controlled Electrophoretic Focusing, Anal. Chem. 1999, 71, 1628-1632.|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US8277830||Oct 4, 2011||Oct 2, 2012||Forsight Vision4, Inc.||Posterior segment drug delivery|
|US8298578||Oct 4, 2011||Oct 30, 2012||Forsight Vision4, Inc.||Posterior segment drug delivery|
|US8399006||Jan 29, 2010||Mar 19, 2013||Forsight Vision4, Inc.||Posterior segment drug delivery|
|US8486052||Dec 27, 2010||Jul 16, 2013||The Johns Hopkins University School Of Medicine||Reservoir device for intraocular drug delivery|
|US8623395||Aug 5, 2011||Jan 7, 2014||Forsight Vision4, Inc.||Implantable therapeutic device|
|US8795712||May 7, 2013||Aug 5, 2014||Forsight Vision4, Inc.||Posterior segment drug delivery|
|US8808727||Mar 15, 2013||Aug 19, 2014||Forsight Vision4, Inc.||Posterior segment drug delivery|
|US8905963||May 7, 2013||Dec 9, 2014||Forsight Vision4, Inc.||Injector apparatus and method for drug delivery|
|US9033911||Aug 5, 2011||May 19, 2015||Forsight Vision4, Inc.||Injector apparatus and method for drug delivery|
|US9066779||Jan 3, 2014||Jun 30, 2015||Forsight Vision4, Inc.||Implantable therapeutic device|
|US9138663 *||Feb 15, 2013||Sep 22, 2015||California Institute Of Technology||Opposed migration aerosol classifier gas and heat exchanger|
|US9180046||Jul 15, 2013||Nov 10, 2015||The Johns Hopkins University School Of Medicine||Reservoir device for intraocular drug delivery|
|US9417238||Nov 14, 2013||Aug 16, 2016||Forsight Vision4, Inc.||Posterior segment drug delivery|
|US9474756||Aug 6, 2015||Oct 25, 2016||Forsight Vision4, Inc.||Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof|
|US9492315||Aug 5, 2011||Nov 15, 2016||Forsight Vision4, Inc.||Implantable therapeutic device|
|US9522082||Mar 3, 2016||Dec 20, 2016||The Johns Hopkins University||Reservoir device for intraocular drug delivery|
|US9526654||Mar 27, 2014||Dec 27, 2016||Forsight Vision4, Inc.||Ophthalmic implant for delivering therapeutic substances|
|US20090250345 *||Apr 3, 2008||Oct 8, 2009||Protea Biosciences, Inc.||Microfluidic electroelution devices & processes|
|US20090250347 *||Nov 17, 2008||Oct 8, 2009||Protea Biosciences, Inc.||Microfluidic devices & processes for electrokinetic transport|
|US20130213860 *||Feb 15, 2013||Aug 22, 2013||California Institute Of Technology||Opposed migration aerosol classifier gas and heat exchanger|
|U.S. Classification||204/450, 204/600|
|International Classification||G01N27/447, G01N27/453, G01N30/28, G01N30/00|
|Cooperative Classification||G01N2030/285, G01N27/44769, G01N2030/0065, G01N30/0005, G01N2030/0025|
|European Classification||G01N27/447C3, G01N30/00A|
|May 28, 2010||FPAY||Fee payment|
Year of fee payment: 4
|May 1, 2014||FPAY||Fee payment|
Year of fee payment: 8